Cargando…

Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study

BACKGROUND: An association between gout and renal disease is well-recognised but few studies have examined whether gout is a risk factor for subsequent chronic kidney disease (CKD). Additionally, the impact of urate-lowering therapy (ULT) on development of CKD in gout is unclear. The objective of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roughley, Matthew, Sultan, Alyshah Abdul, Clarson, Lorna, Muller, Sara, Whittle, Rebecca, Belcher, John, Mallen, Christian D., Roddy, Edward
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235219/ https://www.ncbi.nlm.nih.gov/pubmed/30376864 http://dx.doi.org/10.1186/s13075-018-1746-1

Ejemplares similares

Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink
por: Roddy, Edward, et al.
Publicado: (2023)

Gout and subsequent erectile dysfunction: a population-based cohort study from England
por: Abdul Sultan, Alyshah, et al.
Publicado: (2017)

Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies
por: Roughley, Matthew J, et al.
Publicado: (2015)

Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink
por: Clarson, Lorna E, et al.
Publicado: (2015)

Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction
por: Clarson, Lorna Elise, et al.
Publicado: (2020)

Health-related quality of life in gout: a systematic review
por: Chandratre, Priyanka, et al.
Publicado: (2013)

Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis
por: Clarson, LE, et al.
Publicado: (2015)

A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout
por: Richardson, Jane C., et al.
Publicado: (2016)

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study
por: Paskins, Zoe, et al.
Publicado: (2018)

Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England
por: Russell, Mark D, et al.
Publicado: (2022)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Cohort study investigating gout flares and management in UK general practice
por: Finnikin, Samuel, et al.
Publicado: (2023)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

Illness perceptions of gout patients and the use of allopurinol in primary care: baseline findings from a prospective cohort study
por: Walsh, Ciaran P., et al.
Publicado: (2016)

The association of gout with sleep disorders: a cross-sectional study in primary care
por: Roddy, Edward, et al.
Publicado: (2013)

Obesity, hypertension and diuretic use as risk factors for incident gout: a systematic review and meta-analysis of cohort studies
por: Evans, Peter L., et al.
Publicado: (2018)

Impact of diuretics on the urate lowering therapy in patients with gout: analysis of an inception cohort
por: Ranieri, Laura, et al.
Publicado: (2018)

Factors associated with change in health-related quality of life in people with gout: a 3-year prospective cohort study in primary care
por: Watson, Lorraine, et al.
Publicado: (2022)

Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with Gout
por: Lee, You-Hyun, et al.
Publicado: (2006)

Treatment approaches and adherence to urate-lowering therapy for patients with gout
por: Aung, Thanda, et al.
Publicado: (2017)

Health-related quality of life in gout in primary care: Baseline findings from a cohort study
por: Chandratre, Priyanka, et al.
Publicado: (2018)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
por: Pang, Lei, et al.
Publicado: (2023)

Cost Comparison of Urate-Lowering Therapies in Patients with Gout and Moderate-to-Severe Chronic Kidney Disease
por: Mitri, Ghaith, et al.
Publicado: (2016)

Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study
por: Pisaniello, Huai Leng, et al.
Publicado: (2018)

Foot problems in people with gout in primary care: baseline findings from a prospective cohort study
por: Roddy, Edward, et al.
Publicado: (2015)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

Gout, anxiety, and depression in primary care: a matched retrospective cohort study
por: Prior, JA, et al.
Publicado: (2015)

Comorbidities in polymyalgia rheumatica: a systematic review
por: Partington, Richard, et al.
Publicado: (2018)

Urate-lowering treatment and risk of total joint replacement in patients with gout
por: Kuo, Chang-Fu, et al.
Publicado: (2018)

Vertebral fracture as a risk factor for self-harm: a retrospective cohort study
por: Prior, James A., et al.
Publicado: (2021)

Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients
por: Chung, Ting-Ting, et al.
Publicado: (2019)

The association of gout with socioeconomic status in primary care: a cross-sectional observational study
por: Hayward, Richard A., et al.
Publicado: (2013)

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
por: Becker, Michael A, et al.
Publicado: (2010)

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
por: Jackson, Robert L, et al.
Publicado: (2012)

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
por: Perez-Ruiz, Fernando, et al.
Publicado: (2020)

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
por: Tabi-Amponsah, Adwoa Dansoa, et al.
Publicado: (2023)

Corrigendum to Health-related quality of life in gout in primary care: Baseline findings from a cohort study Seminars in Arthritis & Rheumatism, 48 (2018) 61-69
por: Chandratre, Priyanka, et al.
Publicado: (2022)

Gout. Epidemiology of gout
por: Roddy, Edward, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_evescv7eni6hjk8l9a3g4f599n